News About: Pharm. Industry
Yuhan Corporation, Green Cross and Hanmi Pharm had ‘decent’ business performance in 3rd quarter
The ‘Top5’ pharmaceutical companies have shown a good condition in sales performance in this year’s 3rd quarter.
On the 31st, the ‘Big3’ pharmaceutical companies(Yuhan Corporation, Green Cross and Hanmi Pharm based o...
Can pharma field touch CSOs, still suspicious as ‘Door for Rebates’?
The industry is paying attention to whether CSOs(contract sales organizations) will be investigated as a plan to eradicate illegal rebates, which has continuously suffocated the pharmaceutical industry.
In the circum...
‘Korean Pharmaceutical Industry with Numbers’
The Korea Pharmaceutical and Bio-Pharm Manufacturers Association(Chairman Hee-Mok Won) had the 72th anniversary on this 26th. Starting as the Joseon Pharmaceutical Industry Association in 1945, the association has con...
Handok & Teva-Handok sign joint sales agreement of respiratory disease treatments in Korea
Handok Inc.(Chairman Young-Jin Kim) and Teva-Handok(CEO Sung-Dong Park) held an agreement ceremony for joint sales of Teva-Handok’s respiratory disease treatments at the Handok headquarters on 26 October.
Under the a...
Ildong Pharmaceutical’s challenge to market with its first novel chronic hepatitis B treatment ‘Besivo’ on 1 Nov
‘Besivo,’ the Ildong Pharmaceutical’s(CEO Woong-Sup Yoon) first novel drug and the Korea’s 28th novel drug, will be launched with the National Health Insurance benefit on 1 November. Its insurance benefit will be KRW ...
Boryung Pharm’s antihypertensive Kanarb family achieves over KRW 5 billion monthly sales
The Boryung Pharm’s ‘Kanarb(generic name: fimasartan) family,’ Korea’s first novel hypertension treatments, achieved KRW 5 billion monthly prescriptions.
The Boryung Pharm’s Kanarb family, including 4 drugs, such as ...
Medytox, “Daewoong should not distort essence of the trial”
Medytox(CEO Hyun-Ho Jung) strongly argued an essence of the trial involving the company and Daewoong Pharmaceutical is to reveal the truth if Daewoong Pharmaceutical pirated the company’s botulinum strain and manufact...
Daewoong, “They first need to verify sources of Meditoxin. They have no concrete proof”
The conflict between Medytox, which has had difficulties in entering the U.S. market, and Daewoong Pharmaceutical is getting serious.
As getting an actual dismissal of a civil case that Medytox filed against Daewoong...
Daewoong’s 10 products including Olostar Tab receives 45-day administrative measures
Daewoong Pharmaceutical has taken a bunch of administrative measures of sales suspension on its major products for violating a public advertising prohibition regulation on ETC medicines.
The Ministry of Food and Drug...
What is ‘ISO 37001,’ the new ethical management system for pharmas?
A consulting program for pharmaceutical companies which try to adopt the ‘ISO 37001’ will be prepared from November. As it is shown, the pharmaceutical industry has started to show visible efforts to secure transparen...
